Stock comparison
AbbVie Inc. is 258.9x more valuable than Septerna, Inc. by market capitalization ($441.54 B vs $1.71 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 258.9x more valuable than Septerna, Inc. by market capitalization ($441.54 B vs $1.71 B).
Market value leader
ABBV
AbbVie Inc. is 258.9x more valuable than Septerna, Inc. by market capitalization ($441.54 B vs $1.71 B).
Revenue leader
ABBV
SEPN: $45.95M vs ABBV: $61.16B.
Profit leader
ABBV
SEPN: -$48.88M vs ABBV: $4.23B.
Margin leader
ABBV
SEPN: -106.4% vs ABBV: 6.9% net margin.
| Metric | SEPN | ABBV |
|---|---|---|
| Market cap | $1.71 B | $441.54 B |
| US-listed rank | #2272 | #25 |
| Revenue (latest FY) | $45.95M | $61.16B |
| Net income (latest FY) | -$48.88M | $4.23B |
| Net margin | -106.4% | 6.9% |
| P/E (trailing FY) | - | 104.5x |
| SEC filings | 129 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 258.9x more valuable than Septerna, Inc. by market capitalization ($441.54 B vs $1.71 B).
In their latest fiscal years, Septerna, Inc. reported $45.95M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Septerna, Inc. and AbbVie Inc., or browse the full rankings.